UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 41

Sortiert nach

Linzagolix reduces uterine and fibroid volume

European journal of obstetrics & gynecology and reproductive biology, 2024-02, Vol.293, p.26

2024

Volltextzugriff (PDF)

O-269 Long term efficacy of Linzagolix in women with endometriosis-associated pain

Human reproduction (Oxford), 2024-07, Vol.39 (Supplement_1)

2024

Volltextzugriff (PDF)

O-027 Efficacy results from a phase 3, randomized, placebo-controlled trial testing two doses of linzagolix in women with endometriosis-associated pain

Human reproduction (Oxford), 2023-06, Vol.38 (Supplement_1)

2023

Volltextzugriff (PDF)

Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction

International journal of impotence research, 1996-06, Vol.8 (2), p.47

1996

Volltextzugriff (PDF)

Linzagolix provides rapid, significant reduction of heavy menstrual bleeding in women with uterine fibroids

European journal of obstetrics & gynecology and reproductive biology, 2024-02, Vol.293, p.131

2024

Volltextzugriff (PDF)

Sildenafil: study of a novel oral treatment for erectile dysfunction in diabetic men

Diabetic medicine, 1998-10, Vol.15 (10), p.821-825

1998

Volltextzugriff (PDF)

Sildenafil, a novel effective oral therapy for male erectile dysfunction

British Journal of Urology, 1996-08, Vol.78 (2), p.257-261

1996

Volltextzugriff (PDF)

Development of a Questionnaire on Sexual Quality of Life in Women

Journal of sex & marital therapy, 2005-10, Vol.31 (5), p.385-397

2005

Volltextzugriff (PDF)

A multinational population survey of intravaginal ejaculation latency time

Journal of sexual medicine, 2005-07, Vol.2 (4), p.492-497

2005

Volltextzugriff (PDF)

Sildenafil: study of a novel oral treatment for erectile dysfunction in diabetic men

Diabetic medicine, 1998-10, Vol.15 (10), p.821-825

1998

Volltextzugriff (PDF)

Efficacy and safety of sildenafil citrate in the treatment of men with mild to moderate erectile dysfunction

British journal of psychiatry, 2001-04, Vol.178 (4), p.325-330

2001

Volltextzugriff (PDF)

Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: Rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial

The American heart journal, 2008-10, Vol.156 (4), p.623-632

2008

Volltextzugriff (PDF)

Efficacy of Sildenafil Citrate (Viagra) in Men with Premature Ejaculation

Journal of sexual medicine, 2005-05, Vol.2 (3), p.368-375

2005

Volltextzugriff (PDF)

A 12-WEEK, RANDOMIZED, DOUBLE-BLIND STUDY COMPARING THE EFFICACY AND SAFETY OF VALSARTAN AND ENALAPRIL IN HYPERTENSIVE CHILDREN AGED 6–17 YEARS: PP.27.82

Journal of hypertension, 2010-06, Vol.28, p.e472

2010

Volltextzugriff (PDF)

Sildenafil citrate (VIAGRA): an oral treatment for erectile function with activity for up to four hours' duration

International journal of clinical practice. Supplement, 1999-06, Vol.102, p.32

1999

Volltextzugriff (PDF)

Effect of Nateglinide on the Incidence of Diabetes and Cardiovascular Events

The New England journal of medicine, 2010-05, Vol.362 (18), p.1748-1748

2010

Volltextzugriff (PDF)

Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events

The New England journal of medicine, 2010-05, Vol.362 (18), p.1748-1748

2010

Volltextzugriff (PDF)

The Skin Hyperaemic Response to Local Injection of Substance P and Capsaicin in Diabetes Mellitus

Diabetic medicine, 1990-12, Vol.7 (10), p.898-901

1990

Volltextzugriff (PDF)

Capillary hypertension and abnormal pressure dynamics in patients with essential hypertension

Clinical science (1979), 1990-07, Vol.79 (1), p.5

1990

Volltextzugriff (PDF)

The Effect of Insulin Infusion on Capillary Blood Flow in the Diabetic Neuropathic Foot

Diabetic medicine, 1992-08, Vol.9 (7), p.630-634

1992

Volltextzugriff (PDF)

Efficacy and safety of sildenafil citrate in the treatment of men with mild to moderate erectile dysfunction

British journal of psychiatry, 2001-04 (178), p.325-330

2001

Volltextzugriff (PDF)

Arginine vasopressin in Cushing's disease

The Lancet (British edition), 1990-04, Vol.335 (8696), p.991-994

1990

Volltextzugriff (PDF)

An overview of bilateral synchronous inferior petrosal sinus sampling (BSIPSS) in the pre-operative assessment of Cushing's disease

Australian and New Zealand Journal of Medicine, 1990-12, Vol.20 (6), p.765-770

1990

Volltextzugriff (PDF)

Development of a sexual function questionnaire for clinical trials of female sexual dysfunction

Journal of women's health & gender-based medicine, 2002-04, Vol.11 (3), p.277-289

2002

Volltextzugriff (PDF)

Sildenafil: a novel effective oral therapy for male erectile dysfunction

British journal of urology, 1997-04, Vol.79 (4), p.663-664

Mulhall, J

1997

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(40)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Linzagolix reduces uterine and fibroid volume

O-269 Long term efficacy of Linzagolix in women with endometriosis-associated pain

O-027 Efficacy results from a phase 3, randomized, placebo-controlled trial testing two doses of linzagolix in women with endometriosis-associated pain

Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction

Linzagolix provides rapid, significant reduction of heavy menstrual bleeding in women with uterine fibroids

Sildenafil: study of a novel oral treatment for erectile dysfunction in diabetic men

Sildenafil, a novel effective oral therapy for male erectile dysfunction

Development of a Questionnaire on Sexual Quality of Life in Women

A multinational population survey of intravaginal ejaculation latency time

Sildenafil: study of a novel oral treatment for erectile dysfunction in diabetic men

Efficacy and safety of sildenafil citrate in the treatment of men with mild to moderate erectile dysfunction

Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: Rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial

Efficacy of Sildenafil Citrate (Viagra) in Men with Premature Ejaculation

A 12-WEEK, RANDOMIZED, DOUBLE-BLIND STUDY COMPARING THE EFFICACY AND SAFETY OF VALSARTAN AND ENALAPRIL IN HYPERTENSIVE CHILDREN AGED 6–17 YEARS: PP.27.82

Sildenafil citrate (VIAGRA): an oral treatment for erectile function with activity for up to four hours' duration

Effect of Nateglinide on the Incidence of Diabetes and Cardiovascular Events

Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events

The Skin Hyperaemic Response to Local Injection of Substance P and Capsaicin in Diabetes Mellitus

Capillary hypertension and abnormal pressure dynamics in patients with essential hypertension

The Effect of Insulin Infusion on Capillary Blood Flow in the Diabetic Neuropathic Foot

Efficacy and safety of sildenafil citrate in the treatment of men with mild to moderate erectile dysfunction

Arginine vasopressin in Cushing's disease

An overview of bilateral synchronous inferior petrosal sinus sampling (BSIPSS) in the pre-operative assessment of Cushing's disease

Development of a sexual function questionnaire for clinical trials of female sexual dysfunction

Sildenafil: a novel effective oral therapy for male erectile dysfunction

Suchergebnisse filtern